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Abstract

Traditionally, psychotherapy research has used efficacy and effectiveness studies. Efficacy
studies have been considered the gold standard for studying clinical interventions and effects due
to their stringent controls. While not as scientifically rigorous as efficacy studies, effectiveness
studies examine clinical interventions with larger and more diverse populations and more real-tolife treatment protocols. Unfortunately, effectiveness studies tend to be based on retrospective
report, sometimes many months or even years after the conclusion of psychotherapy. The
growth of technology, in particular smartphone applications (apps) has opened the door to a form
of effectiveness study that allows for real-time data collection. The Therapy Outcome
Management System (TOMS) is an iOS app that offers the potential to collect “big data.” The
data set for this study included 323 Norm Development Associates, who tracked the outcome
and alliance of a total 4,110 clients. Five research questions were considered. The first research
question yielded a statistical difference in therapeutic alliance variables between short-term and
long-term psychotherapy, indicating that long-term psychotherapy patients report statistically
improved therapeutic alliance across 3 of the 5 variables used. The second research question
yielded no significant differences in therapeutic alliance between gender-matched and mixedgender client-therapist dyads. The third research question investigated theoretical orientation/
modality in relation to treatment duration and outcome rating, with three of the four variables
used to measure outcome revealing differences. The fourth research question observed therapy
outcome and treatment duration in various countries where psychotherapy is being conducted,
with significant differences observed. The fifth research question observed outcome and
therapeutic alliance between various diagnostic groups. Individuals with a child/adolescent

BIG DATA FOR RESEARCH

vii

disorder were found to have had statistically higher average outcome ratings in the first 8
sessions when compared to mood disorders, and those in the substance abuse disorder group
reported statistically lower therapeutic alliance scores when compared to adjustment disorder,
anxiety disorder, and child/adolescent disorder. The 5 research questions reported here illustrate
and explore the potential of a novel research method involving big data. Implications and
limitations are considered.
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Chapter 1
Introduction

Research evaluating psychotherapy process and outcomes is crucial in the field of clinical
psychology. Indeed, commitment to research has become a hallmark of health service
psychology insofar as it shapes training, guides treatment, and influences policies established by
the American Psychological Association (APA). For example, the American Psychological
Association 2005 Presidential Task Force on Evidence-Based Practice in Psychology (EBPP)
defined and discussed evidence-based practice in psychology (APA, 2006), emphasizing the
importance of integrating science and practice, and the commitment to EBPP.
Other organizations are also evaluating evidence-based psychological psychotherapy,
such as the National Institute for Health and Clinical Excellence Guidelines (NICE Guidelines)
and Cochrane Reviews. Given the centrality of research in understanding psychotherapy, it is
not surprising that various systems have been identified to study psychotherapeutic process and
outcome.
Two primary outcome research systems have been identified in the literature: efficacy
studies and effectiveness studies (Singal, Higgins, & Waljee, 2014). Now the ubiquity of
smartphone applications (apps) make a modified form of effectiveness studies possible, akin to
what is known in the popular media as “big data.” The purpose of the current study is to
introduce and illustrate a new possibility for psychotherapy research based on data collected by
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psychotherapists using mobile devices. To put this study in context, it is first important to
summarize the two traditional approaches to psychotherapy research.
Efficacy Studies
The efficacy study has been considered the “gold standard” in psychotherapy research
and is often favored in evaluating clinical treatments. Efficacy studies have been used for
conducting clinical trials to evaluate specific interventions in treating psychological disorders.
Thousands of examples of efficacy studies could be offered. For example, a study by Gloster et
al. (2011) evaluated whether therapist-guided exposure within cognitive-behavioral
psychotherapy (CBT) was more effective than CBT treatment without therapist-guided exposure
in the treatment of agoraphobia. The results demonstrated that the therapist-guided exposure was
better for agoraphobic avoidance, overall functioning, and reduction in panic attacks. This study
used randomized assignment, control group, 12-session written manualized treatment, specific
exposure methods, and outcome measures to demonstrate that therapist-guided exposure added
to the effectiveness of CBT in treatment of agoraphobia. As this example illustrates, efficacy
studies tend to be highly controlled and specific to their conditions. Efficacy studies typically
include several key elements.
First, specific inclusion and exclusion criteria are used in order to keep the sample as
uniform as possible. In the example cited here, Gloster et al. (2011) accomplished this by using
participants that met diagnostic criteria of the Diagnostic and Statistical Manual of Mental
Disorders (4th Ed., text rev.; DSM-IV-TR; American Psychiatric Association, 2000) for panic
disorder with agoraphobia. In addition to meeting DSM-IV-TR diagnostic criteria, individuals
had to score significantly elevated on the Hamilton Anxiety Scale (HAM-A) and the Clinical
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Global Impression (CGI). The study used exclusion criteria such as reporting suicidal intent,
borderline personality disorder diagnosis, psychotic disorders, and alcohol dependence. All
participants were required to discontinue all psychopharmacological medication and any other
psychotherapy.
Second, participants are randomly selected to be in a control group or the experimental
group. Randomization is a key feature of true experiments (as opposed to quasi-experimental
studies), making this an important part of efficacy studies. Gloster et al. (2011) also used
stratified sampling that was conducted by the study center. There were two treatment groups that
used two variations of CBT. Both of these groups used the same content, structure, and
treatment duration, but had different implementation of exposure.
Third, there is a control condition where some participants are not receiving the same
intervention that is being delivered to the experimental group. Again, this is a requirement of a
true experiment, and therefore an essential part of efficacy studies. In the Gloster et al. (2011)
study, a single wait-list control was used that did not receive either of the CBT interventions.
Fourth, the treatment is standardized. That is, researchers assure that the treatment is
delivered in a predictable and uniformed way across the various therapists and participants of the
study. Often this involves developing a treatment manual and then testing to be sure that
therapists maintain fidelity to the manual. Gloster et al. (2011) accomplished this by using a 12session written manualized treatment protocol that was used over 6 weeks and followed with two
other sessions. There were two variations of the CBT protocol in this study. One variation used
therapist-guided exposures outside the psychotherapy room. The other had the therapist rehearse
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the exposure procedure with the client and encouraged the patient to implement the procedure
outside of the psychotherapy session.
Fifth, there are efforts to keep evaluators uninformed regarding the identity of particular
participants and whether they are in the control group or the experimental group. In some cases,
there is also an effort to keep participants from knowing which group they are in, or even an
effort to keep treatment providers from knowing some information about the treatment group of
participants. The Gloster et al. study had their clinical coordination center create the randomized
list of patients by personnel that were not a part of patient care.
Sixth, standardized outcome measures with established reliability and validity are used to
evaluate the efficacy of the intervention. This typically involves a repeated-measures design
where the outcome measures are given before and after treatment, and again after a suitable
follow-up period has passed. The same measures are given for the control and experimental
groups. In the Gloster et al. (2011) study outcome variables were assessed at baseline, midtreatment (4th session), post-treatment, and during a 6-month follow-up. The assessment tools
included a Structured Interview Guide for the Hamilton Anxiety Scale, Clinical Global
Impression, number of panic attacks, and agoraphobic avoidance.
Because of these criteria for efficacy studies, they are particularly well-suited for metaanalysis. Meta-analysis is a systemic quantitative review of efficacy research looking at specific
treatments of a particular mental disorder. Meta-analytic studies look at a collection of efficacy
studies to consider the overall effectiveness of treatments, which may then be used for purposes
of treatment planning and subsequent research. An example of such a meta-analysis was
conducted by Vøllestad, Nielsen, and Nielson (2012). The researchers considered mindfulness-

BIG DATA FOR RESEARCH

5

and acceptance-based interventions (MABIs) for treatment of anxiety disorders and other
comorbid symptoms. They considered 19 efficacy studies that employed MABIs for patients
with anxiety disorders and found that MABIs are associated with significant reductions in
anxiety and comorbid depressive symptoms. Hundreds of similar examples could be cited.
It should be noted that efficacy studies may consider treatment groups as compared to
control groups, evaluate various adaptions of established psychotherapies, and directly compare
treatments. An outcome study by Scheeringa, Weems, Cohen, Amaya-Jackson, and Guthrie
(2011) serves as a good example of comparing treatment to no treatment. The researchers
studied whether trauma-focused CBT was effective in treating posttraumatic stress disorder
(PTSD) in young children. The patients were assigned to either a 12-session manualized
treatment or a 12-week wait-list. The study used interviews and checklists to assess for
symptoms of PTSD, major depressive disorder, seasonal affective disorder, oppositional defiant
disorder, and attention deficit/hyperactivity disorder. The results suggested that the treatment
was more effective than the wait-list no-treatment group in reducing PTSD symptoms and
reducing symptoms from comorbid disorders.
A study by Wagley, Rybarczyk, Nay, Danish, and Lund (2013) provides a good example
of how an efficacy study can be used to study an adaption to an already established
psychotherapy. The research tested the efficacy of a two session abbreviated CBT intervention
aimed at treating insomnia as a supplement treatment for psychiatric patients. The study
employed a group that did not receive the supplement intervention and randomly assigned the
patients in the groups. The Pittsburgh Sleep Quality Index (PSQI) and a Patient Health
Questionnaire-9 (PHQ-9) were used as the outcome instruments. Results demonstrated that the
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abbreviated supplemental CBT treatment is beneficial for insomnia and depression in long-term
psychiatric outpatients.
Last, a study by Arch et al. (2012) demonstrates how efficacy studies can be used to
compare different forms of psychotherapy treatments. This study compared CBT to acceptance
and commitment therapy (ACT) for the purpose of treating anxiety disorders. Results suggested
that ACT and CBT showed similar improvement and that ACT is a viable treatment for anxiety
disorders. Efficacy studies show strong possibilities for comparative and explanatory
psychotherapy outcome research.
Due to stringent requirements in efficacy research, the results are considered to be
empirically valid and can easily suggest whether certain psychotherapy approaches should or
should not be used with particular diagnoses. But efficacy studies also have limitations. One of
the biggest challenges for efficacy studies is their cost. They are expensive to conduct, almost
always requiring external funding. Cost also limits the number of sessions that can be included
in clinical trials as well as the number of participants included, which means that some efficacy
studies report the results of relatively brief interventions when longer interventions might be
common in naturally occurring psychotherapy settings. Shean (2012) suggests that efficacy
studies make the assumption that lasting and significant changes occur within a relatively short
time frame, which is not always the case. Most efficacy studies used operationalized and/or
manualized approaches to treatments, and the question is often raised whether these treatments
reflect the real-life practice of clinicians in the field. Another limitation of efficacy studies is
that they often have strict inclusionary and exclusionary criteria. While this is helpful in the
laboratory, it may not reflect the complexity of clients most often seek help for mental health
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concerns. It is common practice to select participants diagnosed with a single Axis I disorder,
which is not always indicative of real-life clinical practice where comorbidity can be present
with various psychological disorders (Shean, 2012). Another limitation can be a lack of cultural
sensitivity. Dependence on manualized treatment might neglect cultural factors that might be
impacting patient’s symptoms and functioning. Finally, clinical trials are well suited for outcome
studies, but not for psychotherapy process. As a result, the studying of outcome and process is
typically segmented into separate studies rather than looking at the two in concert.
Effectiveness Studies
Effectiveness studies, like efficacy studies, can be utilized to evaluate mental health
treatment and outcome. Effectiveness studies attempt to examine clinical interventions more
similar to real-life routine conditions. These studies use more diverse populations, lessstandardized treatment, and focus on more routine clinical settings (Singal et al., 2014).
Effectiveness studies attempt to answer whether the clinical intervention in question works in
real life practice. Whereas efficacy studies have high internal validity, effectiveness studies are
able to achieve high external validity and generalize the results to many settings (Patsopoulos,
2011). Efficacy studies are able to determine causal relationships between variables, but
effectiveness studies are more cost-effective which allows them to have larger samples sizes,
simpler designs, and look at interventions that are difficult to study under a typical efficacy study
method. Seligman (1995) used the Consumer Reports study, which evaluated whether patients
benefited from psychotherapy, as a prime example to demonstrate how effectiveness studies are
able to provide a different way to study psychotherapy outcome.
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Effectiveness studies are typically simpler to conduct than efficacy studies and can lack
the strict structural requirements. The Consumer Reports study utilized a short 26-question
survey about mental health treatment that was sent out embedded in their annual questionnaire in
1994. The questions asked what kind of therapist the individual met with, what presenting
problem was addressed, type of psychotherapy, whether the psychotherapy helped, and other
questions tailored to mental health counseling (Seligman, 1995). The results provided a large
sample size of 2,900 individuals that specifically met with mental health professionals and a total
of 4,100 that saw a combination of mental health professionals, family doctors, and support
groups (Seligman, 1995).
Effectiveness studies also allow for larger-scale and more diverse populations. One
study, if simple enough, can be used to reach population groups in various countries, cultures,
and communities. Though the Consumer Reports survey was sent out only to their subscribers, it
could have been distributed in hospitals, medical clinics, mental health clinics, churches,
community organizations, and any place that has potential contact with individuals that received
psychotherapy in the past. Moreover, the Consumer Reports survey could have been translated
and sent overseas to obtain psychotherapy outcome data from other countries. The research
itself can then be used to observe differences and patterns across cultures, ethnicities, geographic
location, communities, religious, and other demographic domains.
Also, effectiveness studies can be used to assess a wider range of interventions than
efficacy studies. Efficacy studies typically require standardized and/or manualized treatment
protocols, but effectiveness studies can observe a large variety of treatments that do not fit these
stringent requirements. Treatments can be continuous and long term. Seligman (1995) notes that
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the Consumer Reports study included treatment durations from one month or less through two
years or more. This allows the study of longer-term psychotherapy approaches such as
psychodynamic, psychoanalytic, existential, gestalt, and other relational approaches to
psychotherapy.
Notably, there are no control groups in effectiveness studies, as there are in efficacy
studies. This has significant disadvantages from a scientific perspective, though it does allow for
cost-effective studies of large samples where hypotheses can be generated for more rigorous
scientific evaluation in the future.
Finally, effectiveness studies can look at many domains and variables related to the
treatment process. These variables can include client-clinician rapport, attention, motivation,
expectation of gain, and many other variables that are often times not observed through
traditional efficacy studies. The Consumer Report survey asked for therapist competence and
reasons for termination, psychotherapy cost, patient satisfaction, health care reimbursement
policies and limitations on coverage, and other domains parallel to psychotherapy (Seligman,
1995).
Although there are various advantages to an effectiveness study, there are a number of
important limitations. Due to the less stringent requirements for controls and manualized
procedures, experimenters might inadvertently introduce bias into the study by way of sampling
and item selection on survey questions. Also, effectiveness studies typically need large sample
sizes in order to have enough credibility to form conclusions about findings and suggest future
areas of investigation. Moreover, results from effectiveness studies are sometimes too general
and do not possess enough causal or explanatory data for in-depth analysis. The Consumer
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Reports study, for example, points to general conclusions suggesting that no specific
psychotherapy approach was better than another when considering patient satisfaction, and that
psychologists, psychiatrists, and social workers were not different in their effectiveness as
therapists (Seligman, 1995), but it was unable to evaluate the nuanced treatment questions that
can be considered in a highly controlled trial of a manualized treatment.
Mobile Applications for Outcome Data Collection
While efficacy and effectiveness studies have traditionally been used to gather
psychotherapy outcome data, developing technology has provided a potential new method to
gather such information. Specifically, smartphone applications and their widespread reach have
a large potential for psychologists and other psychotherapists to gather data for psychotherapy
research. Using software to gather psychotherapy research can be seen as an extension of the
effectiveness study method. Mobile applications can help gather data quickly and on a
potentially larger scale then traditional effectiveness and efficacy methods. Whereas
effectiveness studies have traditionally been retrospective, asking participants to evaluate their
experiences months or years after the conclusion of psychotherapy, mobile app technology
allows for effectiveness data to be collected in real-time, as psychotherapy is occurring.
One example of this is the Therapy Outcome Management System (TOMS), an
application (app) for iPhone/iPad operating system (iOS) devices that is currently being used to
gather psychotherapy outcome data and alliance data (Wiarda & McMinn, 2012). This app
allows for clinicians to obtain feedback from their clients regarding psychotherapy outcome and
session feedback. Software such as the TOMS and other applications tailored to gather
psychotherapy data have substantial advantages for clinical and research practices.
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Using mobile applications that are readily available through common distribution
channels such as the Apple iTunes Store promotes large distribution and usage. The open
availability of the software allows clinicians all over the world to use the app and track patient
outcome. The client outcome, session feedback, and demographic information is de-identified
and stored on a cloud server for research access. This method allows researchers to access the
data from anywhere and the data can come from a large number of settings such as psychology
clinics, primary care clinics, and other centers where psychotherapy is conducted. Traditional
efficacy and effectiveness studies can be limited by the sample sizes. Outcome mobile
applications such as the TOMS allow for public distribution which encourages very large sample
sizes for research analysis.
The adaptability of mobile applications is important when considering psychotherapy
research applications. Mobile applications are usually developed and coded by one or more
programmers. The software can be tailored and modified to fit specific research needs such as
client type, intervention method, clinical settings, demographics information, and other domains
for study. Even after an application is initially launched the application can be updated,
modified, and altered for improvements and needed changes. Using software for psychotherapy
outcome research adds a level of versatility and adaptability that is difficult to reach with other
methods of study. Traditionally once studies have started, there are no ways to modify for
potential problems. For example, the TOMS app gathers demographic information and outcome
data using the ORS and SRS outcome measures. Hypothetically, the TOMS app could be
modified to gather other information such as physical characteristics like weight, height, and
even use other outcome measures that are already established in a clinical setting. The software
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can be translated into various languages to accommodate the diversity of the clinical population
and setting. Although making modifications to an application would takes resources and time,
the adaptability of the software allows the data collection to account for all the specific
characteristics the specific clinical settings needs to observe.
Thus, one application can be set up to collect information in various clinical settings, with
multiple language groups, and potentially gather extremely large sample sizes for psychotherapy
outcome research. The ability to adapt the software to account for all the demands and needs of
the clinical settings, and also the ability to endlessly collect psychotherapy outcome data with no
additional difficulties offers a new potential for psychotherapy outcome research that is not
common in today’s research.
Another appeal for using smartphone applications for outcome research is the simplicity
of use. Efficacy studies are usually more complicated and take longer to develop than
effectiveness studies. Clinicians must usually be trained on a specific intervention and follow a
specific manualized treatment for a particular study. In contrast, using a mobile app requires
only minor changes in how the clinician practices psychotherapy. The app must be used at the
beginning and/or end of the psychotherapy to obtain outcome and alliance information but other
than that, it does not affect the flow of psychotherapy during clinical practice. The TOMS app,
as an example, would require the therapist to possess a mobile tablet or phone with the TOMS
software and simply ask the client to fill out the outcome and alliance measures to gather the
patient’s feedback. The ease of use promotes using the app in every psychotherapy session as
long as the clinician brings it into the psychotherapy room. Using the app also allows for rapid
data collection and secure storage of the data. The software automatically stores and uploads de-
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identified outcome data to a large database for research purposes. From the clinician’s point of
view, the application offers outcome tracking and secure storage which is easily accessible for
clinical purposes. The amount of outcome data obtained would only be limited by distribution
and the clinician’s use of the software. Thus, if the distribution and accessibility is on a worldwide scale a single app could monitor outcome on multiple continents, and monitor outcome data
on potentially millions of clients.
However, there are also potential downsides with using mobile software for
psychotherapy outcome data collection. The first and most significant issue is how the app will
reach the psychotherapy room. The software app needs to run on a certain type of device, like a
tablet, so the clinic, clinician, or organization must obtain these devices in some way. People
might ask whether certain organizations even allow the use of such software to track outcome
data, and will the organization deem the software secure enough for confidentiality purposes?
These questions need to be answered before a large organization adopts a mobile app for
outcome data collection. Private practice or smaller organizations might have an easier time
adopting the software, but the cost of the tablet or device needed to run the software might be a
challenge for private practitioners and smaller clinics. A significant challenge is also to figure
out a method to integrate mobile applications with the electronic health/medical records
(EHR/EMR). Although possible, there are formidable obstacles to incorporating a new measure
in a EHR. However, there are many relevant applications for the outpatient environment. The
most obvious is for clinicial feedback, but it could also create efficient and accurate information
for payers who require outcome data for continued authorization of care. This method might be
a way to cleanly collect the research data, but poses many challenges in security and integration.
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Another potential issue is the cost of the software. Even if the software is free to use, it needs to
provide substantial benefits for the clinician or clinical organization. The application also needs
to be in line with the expectations of the clinician. If the software is not directly benefiting the
clinical practice and if it does not meet the clinician’s expectations, the software might not be
used.
Another issue results directly from the software’s distribution. If the application is not
readily available or commonly used, will the application have enough exposure for
psychotherapy outcome research? This is especially the case when talking about studying
specific populations or groups. If there are significant issues with reaching psychotherapists and
instilling regular use of the application, the data gathered might not have enough power for
research purposes. Even if the device and app are readily available, and are adopted by many
clinical organizations, there is a question whether clinicians or organizations will use it regularly.
The software might appear promising and used regularly for a period of time, but it is unknown
whether the software will be used for weeks, months, or years regularly and consistently. The
consistency and regularity of use will affect data collection and whether the data can be used for
longer-term longitudinal analyses.
Another issue regarding outcome tracking applications is the developer and development
costs of such applications. Although learning how to code and program software is possible, the
task is usually performed by experts outside the psychotherapy and psychology research fields.
Developing and modifying such applications requires extensive skill, time, and resources which
often means hiring professional software developers to build such programs. Hiring
professionals for the purposes of application development adds additional expenses to collect the
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research data. Even if the application were developed by a researcher, additional modification
and maintenance of the application might require additional expenses and resources. The longterm use of an outcome application for data collection can be cost-effective, but there can be a
large amount of start-up costs with no fail-proof way to ensure that the application is successful
in reaching a large number of clinicians and clients.
Finally, one must consider ethical issues in using software for gathering psychotherapy
outcome data. According to the APA (2009), confidentiality and privacy are significant
challenges that arise when incorporating technology into psychological practice. Security of the
information obtained using such applications is essential and must be done with high standards.
Using mobile applications for patient outcome tracking might require special methods of deidentification client’s personal information but at the same time allowing long-term tracking of
each client’s outcome feedback. If de-identification is not possible from the programming
standpoint, both obtaining patient consent and ensuring the security of the database are essential.
Another ethical consideration is how the outcome data will be used. Will the information be
used for pure research purposes set by the developer/researcher who created the application, or
will the data be available for the general or limited public for research and other reasons? If an
outcome tracking application becomes vastly popular and accepted by psychotherapy
practitioners and organizations, third-party payers might eventually want to base psychotherapy
reimbursements on outcome data obtained for specific clinicians and interventions. For example,
if the outcome data and research demonstrates that a specific clinician was able to achieve
symptom reduction and good outcome using a CBT approach within eight weeks for a specific
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disorder, third-party payers might not want to pay clinicians or interventions that take longer to
achieve similar results.
Ethics regarding confidentiality and how this data collection method will be used is
something that will need to be addressed and analyzed. However, the potential for using
outcome tracking software is unprecedented. To demonstrate the potential use of a
psychotherapy outcome application, the TOMS app will be used to answer a number of research
questions pertaining to psychotherapy.
The first study will observe changes in therapeutic alliance over various treatment
durations. Specifically, the study will compare therapeutic alliance in short-term versus longterm psychotherapy. Research has suggested that client’s with lower therapeutic alliance are
more likely to drop out of psychotherapy (Sharf, Primavera, & Diener, 2010). Within the TOMS
app this would be observed within shorter psychotherapy treatment durations. For the purposes
of this study, short-term psychotherapy will include psychotherapy that lasts 1 to 8 sessions.
Treatment that continues past 8 sessions will be considered long-term.
The second question will ask whether gender differences between client and therapist are
related to therapeutic alliance and treatment duration. A study by Wintersteen, Mensinger, and
Diamond (2005) observed whether gender and racial differences between patient and therapist
affect therapeutic alliance and treatment retention in adolescents. Their results suggested that
gender-matched dyads have higher therapeutic alliance and that the clients in these dyads were
more likely to complete treatment. Racial matching suggested higher retention but no significant
differences between patient-rated alliance. The TOMS data set will be used to observe the
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relationship between client/therapist demographics and therapeutic alliance and treatment
duration.
The third research question will ask whether theoretical orientation/modality is related to
treatment duration and outcome. There are many different theoretical orientations that are used
by practicing psychotherapists. From traditional psychoanalysis to newer approaches such as
Acceptance and Commitment Therapy, most theoretical orientations have some idea of how long
psychotherapy should last to obtain significant improvements in functioning and symptom
reduction. Some approaches traditionally have been known for longer-term psychotherapy such
as psychoanalytic psychotherapy. However, long-term psychotherapy has been harder to study
and as a result less supported empirically. Cognitive-behavioral psychotherapy and similar
approaches such as Trauma Focused Cognitive Behavioral Therapy have been shown to be
effective forms of short-term psychotherapy (Deblinger, Mannarino, Cohen, Runyon, & Steer,
2011). A study by McClelland (2014) suggests that CBT initially demonstrated higher scores on
outcome measures when compared to those of psychodynamic psychotherapy. However, the
overall-interaction between time, theoretical modality, and length of psychotherapy suggests that
patients who stayed in psychotherapy for an average treatment duration achieves similar results
regardless of theoretical modality. The TOMS large data set will be used in an attempt to
replicate these findings and further analyze the interaction between theoretical
orientation/modality, treatment duration, and patient outcome.
The fourth question will study whether the psychotherapist’s country of orgin affects
outcome or alliance ratings. The TOMS’ app collects information such as age, gender, ethnicity
of client, and the country where psychotherapy is being conducted. Factors such as
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client/therapist demographics and their relationship to psychotherapy are extremely difficult to
study due to confounding variables that are present within psychotherapy sessions. However,
with large amounts of data on thousands of clients, the data might have the power to suggest
differences in initial outcome ratings related to demographic factors. The outcome scores will be
assessed during the first eight sessions of psychotherapy and analyzed.
The fifth question will observe differences in outcome and alliance ratings related to
various diagnostic criteria. A study by Falkenström, Granström, and Holmqvist (2013) observed
a relationship between alliance and symptom change in psychotherapy patients. Reduction in
patient symptoms suggested improvements with therapeutic alliance, and oppositely, diminished
alliance correlated with worsening of symptoms. Furthermore, the results suggested that patients
with reported personality problems showed stronger variance in alliance between sessions when
compared to other patients. Though the data from the TOMS app does allow this sort of nuance
to be investigated, it also allows for large-scale consideration of diagnosis in relation to outcome
and alliance. The TOMS app looks at 13 diagnostic categories: adjustment disorder, anxiety
disorder, child/adolescent disorder, cognitive impairment, dissociative disorder, eating disorder,
mood disorder, personality disorder, schizophrenia, sexual disorder, sleep disorder, somatoform
disorder, and substance abuse.
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Chapter 2
Methods
Instruments
Therapy Outcome Management System (TOMS). The TOMS has been available in
the Apple App store since May, 2012. Therapists who have bought the app or received a
redemption code from the developer have been tracking outcome, therapeutic alliance, and
demographic data for their individual clients. The app can be used on an iPad or iPhone/iPod
and is intended to be used in every psychotherapy session to collect therapeutic alliance and
outcome scores. The TOMS app has been used to gather psychotherapy outcome and/or working
alliance data from over 20,000 sessions, with that number continuously increasing. The TOMS
app uses two measures, the Session Rating Scale (SRS; Duncan et al., 2013, see Appendix A) to
measure therapeutic alliance and the Outcome Rating Scale V3.0 (ORS; Miller, Duncan, Brown,
Sparks, & Cloud, 2013, see Appendix B) to measure psychotherapy outcome. Both measures
use a visual analog scale to measure four items in each of the measures. Traditionally, patients
were asked at each treatment session to make a visible mark were using paper and pen on the
spectrum where their perceptions are in the various items. Each item spectrum on the SRS and
ORS is ten centimeters in length. The SRS and ORS are scored by measuring the distance in
centimeters between the patient’s mark and the left pole of each spectrum. Once each item is
scored, the four items in each assessment are added together to obtain the total score. The TOMS
app uses an iPad or iPhone to administer the SRS and ORS with the same consistency and
accuracy, though the actual length of the item spectrum depends on the device size rather than
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being ten centimeters. The TOMS app handles scoring automatically rather than using the
manual procedures used with the pencil-and-paper versions.
The TOMS app allows for the data to be collected electronically in real time on a sessionby-session basis during mental health treatments. The patient and therapist information is then
de-identified through security algorithms and the data is uploaded for analysis. In addition to
gathering outcome and therapeutic alliance data, the TOMS app provides the option for
psychotherapists to report demographic information about themselves and their clients, such as
age, gender, country of practice, level of training, theoretical orientation/modality, and the
diagnostic category of the presenting problem.
Session Rating Scale (SRS). The SRS is a 4-item visual analog measure designed to
assess working alliance in psychotherapy. During psychometric evaluation the SRS was
compared to the Helping Alliance Questionnaire II (HAQ-II; Luborsky et al., 1996).
Psychometric testing of the SRS suggests that it is a valid and reliable measure of alliance and
has moderate test-rest stability. When compared to the HAQ-II, the SRS showed a Cronbach’s
coefficient alpha of .88, which is similar to the HAQ-II (.90). Test-rest reliability which was
calculated using Pearson’s r was .64 (HAQ = .63). Concurrent validity testing showed there was
a .48 correlation between the SRS and HAQ-II, suggesting a reasonable degree of concurrent
validity of the SRS. The SRS also demonstrated a correlation of .29 between outcome measures
administered at the end of psychotherapy and during second and third psychotherapy sessions.
The validity testing suggests that the SRS is moderately related to an established self-report
measure of alliance (Duncan et al., 2003).
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Outcome Rating Scale (ORS). The ORS is a 4-item visual analog measure of overall
patient well-being. During development it was compared to the Outcome Questionnaire 45.2
(OQ-45.2; Lambert et al., 1996). When compared to the OQ-45.2, the ORS showed an internal
consistency of .93 (Cronbach’s alpha) (OQ-45.2 = .93). Concurrent validity was compared with
the OQ-45.2 at various administration times using the Pearson’s r. The overall correlation
between the ORS and OQ-45.2 was .59, which indicates moderate concurrent validity. The
validity testing suggested that the ORS is similar to an established self-report outcome scale
(Miller et al., 2003).
Participants
Participants for study include the therapists that are currently using the app for outcome
tracking. When first installing the app, they are given opportunity to participate as a “Norm
Development Associate,” which means the data collected from their use of the app are deidentified and uploaded to a server for psychotherapy research purposes. Agreeing to be a Norm
Development Associate constitutes consent for purposes of this study. As is true of all informed
consent procedures, users of the TOMS app can choose at any time to discontinue serving as a
Norm Development Associate.
As of February, 2015, the TOMS app had 504 Norm Development Associates (140 male,
173 female, 189 gender not specified, 2 other; age range: 15-72 years) who were tracking
outcome of a total of 7,318 clients (1,217 male, 3,700 female, 2,401 gender not specified, age
range: 1-91 years). Patients are ethnically diverse with individuals identifying themselves with a
specific ethnicity, but most patients did not select an ethnicity (22 Asian, 112 Black, 49 Dutch, 3
Niet-Dutch, 38 Hispanic/Latino, 17 Indigenous, 714 White, 27 mixed, 28 that indicated other
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ethnicities, and 6,308 did not select an ethnicity). Note that ethnicities must be categorized
somewhat differently than what is typically done in the United States in order to accommodate
the worldwide distribution and use of the app. Therapists have various theoretical
orientation/modality for treating mental health problems.
Although the TOMS app obtains a large amount of session data, not every therapist that
uses the app completes all the demographic and diagnostic information about themselves or their
patients. Thus, depending on the research question, the data set has been filtered to include only
the patients and therapists that fill the requirements for that study.
Procedures
This is an archival research endeavor. Data is securely stored in a web-based server and
was de-identified so that therapists’ and clients’ identity can never be known. Each session,
patient, and therapist has a unique identification number, generated by an MD5 hash technology.
This allows for a unique and secure identification number to be created with assurance that it
cannot be unencrypted. Currently there are two separate data files stored in the server – one for
the SRS and one for the ORS.
Data from the two data files was reorganized and merged using custom software. Once
the custom data file was created, it was exported to SPSS for the purposes of this study. Each of
the five research questions was analyzed with SPSS.
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Chapter 3
Results
Question 1
The first research question investigated therapeutic alliance between short-term and long
term therapy. A series of independent samples t-tests were conducted to compare therapeutic
alliance (measured by the SRS) in short-term versus long-term psychotherapy. For this analysis
short-term psychotherapy referred to treatment that consisted of eight or less psychotherapy
sessions. Long-term psychotherapy referred to treatment that consisted of nine sessions or more.
In addition, the data were filtered to include only clients that completed the SRS. Five variables
were used to measure differences in therapeutic alliance: SRS slope, most recent SRS total score,
average SRS total rating, SRS total ratings from first and eighth session. A linear regression was
used to calculate the SRS total slope by measuring the slope between each session until the
eighth session. The average slope for the first eight sessions was observed for both short-term
and long-term therapy groups. The SRS total score from each client’s most recent
psychotherapy visit was identified and a mean was determined for the patients found within their
first eight sessions and those individuals that are past eight visits. The average SRS total
variable was determined by finding the average SRS total score for each client in both the longterm and short-term psychotherapy groups. SRS ratings from the first and eight sessions were
identified as snapshots of SRS scores in both the short-term and long-term psychotherapy
groups. Table 1 describes t-test results and differences found between the variables.
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Table 1
Results for Question 1: Differences in Therapeutic Alliance in Short-Term and Long-Term
Psychotherapy

Variable

Short-term
Group

Long-term
Group

Differences

Mean (Std dev) Mean (Std dev)
Session 1 SRS Total

Session 8 SRS Total

Most Recent SRS Total

SRS Slope first 8 sessions

Average SRS Total

34.55 (5.51)
N = 1419

35.38 (5.09)
N = 852

t (1906) = 3.64, p < .001,
Cohen’s d = 0.156

36.77 (4.50)

36.90 (4.64)

t (895) = .06, p = .950

N = 139

N = 758

36.02 (5.22)

37.53 (4.52)

N = 1182

N = 652

t (1510) = 6.44, p < .001,
Cohen’s d = 0.309

.19 (.75)

.22 (.64)

t (795) = .59, p = .555

N = 125

N = 672

35.30 (4.65)

36.69 (3.83)

N = 1642

N = 985

t (2380.74) = 8.33, p <.001,
Cohen’s d = 0.326

Note. Short-term group consists of those completing 8 sessions or fewer. Long-term group
consists of those completing 9 or more sessions.

Question 2
The second research question investigated therapeutic alliance and treatment duration
between gender-matched and mixed-gender client-therapist dyads. An independent samples ttest was conducted to compare therapeutic alliance and treatment duration between gendermatched and mixed-gender client-therapist dyads. Therapist alliance was again measured by the
SRS and treatment duration was measured by number of attended sessions. Data analysis of the
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SRS included these four variables: most recent SRS total score, average SRS total rating, average
SRS in first 8 session, and average SRS change. The most recent SRS total score is the
measured SRS score at the most recent therapy session. The average SRS total rating was the
calculated mean of all the completed SRS total ratings from each client. The average SRS in
first eight sessions was the calculated mean of the SRS total ratings obtained in the first eight
sessions of psychotherapy. The average SRS change was calculated by computing the difference
from one session to the next and then averaging these change scores. Table 2 describes t-test
results and differences found between the variables.

Table 2
Results for Question 2: Difference in Therapeutic Alliance and Treatment Duration in GenderMatched and Mixed-Gender Client-Therapist Dyads.
Mixed Gender
Dyad Group
Variable

(N = 1494)

Matched
Gender Dyad
Group
(N = 1433)

Differences

Mean (Std dev) Mean (Std dev)
Most Recent SRS Total

35.24 (5.87)

34.89 (6.01)

t (2116) = 1.34, p = .181

Average SRS Total

35.03 (5.22)

34.66 (5.48)

t (2618) = 1.78, p = .075

Average SRS in first 8

34.95 (5.24)

34.58 (5.49)

t (2614) = 1.77, p = .077

Average SRS Change

.28 (2.80)

.46 (3.38)

t (1635) = 1.15, p = .248

Treatment Duration

5.82 (8.02)

5.49 (7.25)

t (3082) = 1.15, p = .250

Sessions

Note. A matched gender dyad group consists of a client-therapist pair that shares the same
gender. A mixed gender dyad group consists of a client-therapist pair that does not share the
same gender. The data set only allowed for use of female and male in the gender category.
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Question 3
The third research question investigated theoretical orientation/modality in relation to
treatment duration and outcome ratings. A one-way ANOVA was conducted to compare
treatment duration and outcome ratings of therapy sessions from different psychotherapist
orientation/modalities. A Scheffe post-hoc test was used to obtain specific comparisons between
the theoretical orientation/modalities. There are nine options for psychotherapists to choose
from on the TOMS application for theoretical orientation/modality: Cognitive-Behavioral,
Integrative, Eclectic, Psychodynamic, Family Systems, Humanistic, Interpersonal, EmotionFocused, and other. The treatment duration variable was measured by number of sessions that
were recorded per client in the TOMS. The variables used to measure outcome were average
ORS change, most recent ORS total, average ORS total rating, and average ORS total in first
eight sessions. These four outcome variables were calculated identically to the SRS variables in
Question 2. Treatment duration was again measured by number of attended sessions. Tables 3
displays the one-way ANOVA and Scheffe post hoc differences between the theoretical
orientation/modalities. Statistical differences were determined measured by a p value < 0.05.
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Table 3
Results for Question 3. One-way ANOVA and Scheffe post hoc results for outcome rating and
treatment duration variables in theoretical orientation/modality groups.
Variable

F (df)

p

Post Hoc differences

Most Recent ORS Total

F (8, 4939) = 10.346

p < 0.001

CBT < IN, EC, OTH
OTH > CBT, FS, IP
IP < IN, EC, OTH

Average ORS Total

F (8, 5046) = 10.896

p < 0.001

OTH > CBT, IN, EC, FS, IP

Average ORS in first 8
Sessions

F (8, 5046) = 10.677

p < 0.001

OTH > CBT, IN, EC, FS, IP

Average ORS Change

F (8, 3465) = .945

p = 0.478

No statistical differences

Treatment Duration

F (8, 5202) = 10.722

p < 0.001

CBT < IN, EC, FS
IN > CBT, HU, IP, EFT
FS > CBT, IP, EFT
EFT < IN, EC, FS, OTH

Note. Results include comparing outcome and treatment duration variables between nine
theoretical orientation/modality groups: Cognitive-Behavioral (CBT), Integrative (IN), Eclectic
(EC), Psychodynamic (PD), Family Systems (FS), Humanistic (HU), Interpersonal (IP),
Emotion-Focused (EFT), and Other (OTH).

Question 4
The fourth research question investigated outcome ratings and treatment duration
between countries where psychotherapy is being conducted. A one-way ANOVA was conducted
to compare outcome ratings of therapy sessions from various countries where the TOMS
application is being used. The Scheffe post hoc test was used to measure individual differences
in outcome ratings between the different countries. There are currently eleven countries being
represented within the TOMS data: Australia, Canada, Denmark, Netherlands, New Zealand,
Norway, Philippines, Romania, Sweden, United Kingdom, and USA. The variables used to
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measure outcome were average ORS change, most recent ORS total, average ORS total ratings,
average ORS total in first eight sessions, and average ORS slope. The first four variables were
calculated identically to the ORS variables in Question 2. The average ORS slope was
calculated by averaging the measured slope of the total ORS ratings from each session to the
next. Treatment duration was again measured by number of attended sessions. Table 4 displays
the one-way ANOVA and Scheffe post hoc differences between countries in which therapy was
conducted. Statistical differences were identified by a p value < 0.05.
Question 5
The fifth research question investigated potential differences in outcome and session
ratings between various diagnostic groups. A one-way ANOVA was conducted to compare
outcome and session ratings of therapy sessions from various diagnostic groups within the
TOMS data. A Scheffe post hoc test was used to measure individual differences in outcome
ratings and therapeutic alliance between the various diagnostic groups. There were at total of 8
diagnostic categories that had adequate sample size within the TOMS data: Adjustment disorder,
anxiety disorder, child /adolescent disorder, eating disorder, mood disorder, personality disorder,
substance abuse, and other. The variables used to measure outcome were most recent ORS total,
average ORS total, average ORS in first 8 sessions, average ORS change, and average ORS
slope. The variables that are measuring therapeutic alliance are: most recent SRS total, average
SRS total, average SRS in first 8 sessions, average SRS change, and average SRS slope. These
variables were calculated identically to the ORS and SRS variables in previous research
questions. Table 5 displays the one-way ANOVA and Scheffe post hoc differences between
diagnostic criteria label of clients. Statistical differences were identified by a p value < 0.05.
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Table 4
Results for Question 4. One-way ANOVA and Scheffe Post Hoc Results for Outcome Rating
Variables in Country of Origin Groups
Variable

F (df)

p

Post Hoc Differences

Most Recent ORS Total F (10, 4924) = 16.363 p < 0.001

AU < NL, UK, US
UK > AU, CA, DK, NZ, SE, US

Average ORS Total

F (10, 5030) = 31.363 p < 0.001

NL > AU, CA, NZ, UK
UK > AU, CA, DK, NL, NZ,
NO, RO, SE, US
US > AU, CA, NZ, UK

Average ORS in first 8
Sessions

F (10, 5030) = 29.379 p < 0.001

AU < NL, UK, US
NL > AU, CA, NZ
NZ < NL, UK, US
UK > AU, CA, DK, NL, NZ,
NO, RO, SE, US

Average ORS Change

F (10, 3462) = 7.142

p < 0.001

AU > US
NZ > NL, UK, US

Average ORS Slope

F (10, 3412) = 6.191

p < 0.001

NZ > NL, US,
US < AU, NZ

Treatment Duration

F (10, 5187) = 24.863 p < 0.001

PH > AU, CA, DK, NZ,
RO > AU, CA, NZ
UK > AU, CA, DK, NL, NZ,
SE, US
US > AU, CA, NZ, UK

Note. Results include comparing outcome and treatment duration variables between eleven
country groups: Australia (AU), Canada (CA), Denmark (DK), Netherlands (NL), New Zealand
(NZ), Norway (NO), Philippines (PH), Romania (RO), Sweden (SE), United Kingdom (UK), and
United States (US).
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Table 5
Results for Question 5. One-way ANOVA and Scheffe Post Hoc Results for Outcome and Session
Ratings Between Diagnostic Groups
Variable

F (df)

p

Post Hoc Differences

Most Recent ORS Total F (7, 541) = 2.103

p = .042

No post hoc differences < .05

Average ORS Total

F (7, 565) = 2.535

p = .014

No post hoc differences < .05

Average ORS in first 8

F (7, 565) = 2.546

p = .014

MD < CD

Average ORS Change

F (7, 385) = .982

p = .444

No statistical differences

Average ORS Slope

F (7, 372) = .209

p = .983

No statistical differences

Most Recent SRS Total

F (7, 425) = 2.087

p = .044

No post hoc differences < .05

Average SRS Total

F (7, 515) = 3.118

p = .003

SA < AD, AX, CD

Average SRS in first 8

F (7, 515) = 3.175

p = .003

SA < AD, AX,CD

Average SRS Change

F (7, 327) = .949

p = .469

No statistical differences

Average SRS Slope

F (7, 319) = .856

p = .542

No statistical differences

Sessions

Sessions

Note. Results include comparing outcome and session ratings between eight diagnostic criteria
groups: Adjustment Disorder (AD), Substance Abuse (SA), Anxiety disorder (AX), Eating
disorder (ED), Personality disorder (PD), Mood disorder (MD), Child/adolescent disorder (CD)
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Chapter 4
Discussion

This study explored the use of the Therapeutic Outcome Management System (TOMS)
mobile app to gather psychotherapy research data. Five research questions were used to explore
the potential of using the TOMS and also the limitations of using such technology. The five
questions explored differences in (a) therapeutic alliance when compared to treatment durations,
(b) therapeutic alliance and treatment duration when comparing gender between client and
therapist, (c) treatment duration and outcome ratings between various theoretical
orientations/modalities, (d) outcome ratings and treatment duration between country of origin,
and (e) therapeutic alliance and outcome ratings across diagnostic criteria.
Summary of Findings
In response to the first research question, it appears that shorter-term therapy is associated
with lower therapeutic alliance. This was evident in the first session ratings, most recent session
ratings, and average session rating scores. Though significant differences were found, effect
sizes are quite small. It is also important to consider that within shorter-term psychotherapy
group there might have been a significant number of drop outs that occurred for various reasons.
A meta-analysis by Sharf et al. (2010) indicates that there are higher levels of drop-outs when
therapeutic alliance is lower—a finding which is consistent with the results reported here. The
present findings also suggest that when treatment reaches eight sessions there were no significant
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differences observed in therapeutic alliance between the shorter-term and longer-term
psychotherapy groups.
The second research question suggested no significant differences between gendermatched and mixed-gender client-therapist dyads in the current study. Add The most recent SRS
total, average SRS total, average SRS in first 8 sessions, and average SRS change variables did
not provide significant differences between the two groups. Likewise, the analysis on the
treatment duration between the two groups suggested no significant differences. This was
contrary to the results reported by Wintersteen et al. (2005) which suggested that gendermatched dyads have higher therapeutic alliance and that their clients are more likely to complete
treatment.
The third research question considered the association between psychotherapist
theoretical orientation/modality, outcome rating, and treatment duration. The “other” theoretical
orientation/modality was statistically greater in the average ORS total and average ORS in first 8
sessions when compared to cognitive-behavioral, integrative, eclectic, family systems, and
interpersonal approaches. Apart from the “other” theoretical orientation/modality option, few
differences were observed in the outcome rating variables across the various theoretical
orientation/modalities. The cognitive-behavioral group was found to have lower most recent
ORS total scores than integrative, eclectic, and those with “other” as a theoretical
orientation/modality. Statistical significant differences were also observed among treatment
duration and theoretical orientations/modalities. Integrative and Family Systems groups were
found to have the statistically higher number of sessions. Cognitive-Behavioral and EmotionFocused groups were found to have the least number of sessions.
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The fourth research question considered therapy outcome and treatment duration in
various countries where psychotherapy is being conducted. Many differences were observed
between outcome ratings and selected country. Individuals in the United Kingdom tended to rate
their outcome more favorably when compared to most of the other countries. This was evident
across three different variables for outcome ratings scores. Interestingly, the results also
indicated that clients in the UK also stayed in treatment statistically longer than clients in most
other countries. Individuals in Australia tended to have statistically significantly lower outcome
ratings on their most recent rating when compared to the United States, United Kingdom, and
Netherlands.
The last research question considered outcome and therapeutic alliance between various
diagnostic groups. These results revealed few statistical differences among groups. However,
individuals with a child/adolescent disorder had statistically higher average outcome ratings in
the first eight sessions when compared to mood disorders. The substance abuse disorder group
was also found to have statistically lower therapeutic alliance scores when compared to
adjustment disorder, anxiety disorder, and child/adolescent disorder.
Implications
The use of the Therapy Outcome Management System (TOMS) iOS app has many
implications for researchers of psychotherapist data. One of the most important implications is
that the app allows for collection of big data due to its ease of access and public availability. The
app is available to anyone that has a device that allows iOS applications, thereby allowing for a
very large sample size and providing the researcher with enough power to identify small
statistical differences.
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Detecting small differences has both advantages and disadvantages. One advantage is
that the power of the large samples may help detect subtle nuances that would otherwise not be
observed in traditional efficacy studies. Conversely, it is likely that these small differences –
some of which have tiny effect sizes – might be exaggerated when considering clinical
implications.
The data collection reported here happens in real-time and continues to change with
added Norm Development Associates and new clients. This has at least two implications for the
researcher. First, the data and thus the results are continuously changing. Second, the research
can access a worldwide sample of therapists and their patients. As is true of science in general,
this calls for holding conclusions with some tentativeness and replicating studies often to see
which conclusions stand the test of time.
While traditional efficacy studies attempt to control for many variables and use
manualized treatment when possible, using a mobile app to enables the researcher to sample
therapeutic alliance and outcome directly in “real-life” clinical settings. This means that the app
collects information from clinics, clinicians, and patients from all over the world where this iOS
app is available. Global access to participate in psychotherapy research such as this app is due to
the technological advances in smartphone technology. With more countries and people around
the world obtaining access to such technology, these types of apps that have the potential to
gather psychotherapy data could be significant contributors to developments in clinical
psychology literature.
This type of data gathering is currently being utilized on a somewhat smaller scale in
many large medical organizations in the collection of screeners such as the Patient Health
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Questionnaire (PHQ-9) and SBIRT (Screening, Brief Intervention, Referral to Treatment).
Although screeners and other measures are often used within both primary care and outpatient
mental health clinics, the data are usually self-contained within that specific organization. Many
times they are being stored but not analyzed. Moreover, paper and pencil are still being used in
some primary care offices with patients, but with developments in technology these medical
organizations might start using tablets and other forms of mobile technology for convenience,
ease of service, and data analysis purposes. If organizations start utilizing tablets and other
mobile device the development of application such as the TOMS creates more opportunities for
data collection across many organizations and the ability to reach those in smaller practices. The
benefit of this technology is that it does not only benefit individual organizations and researcher,
but its individual benefit for clinicians.
The TOMS app specifically provides good incentives for clinicians by its use of
statistically valid and reliable measures. The app is fairly easy to use, quick to administer, and
shown to have no difference from paper and pencil administration of the SRS/ORS (Wiarda,
2012). The app allows clinicians to measure and monitor their therapeutic alliance and outcome
of their clients, while contributing to an ever-growing data pool.
This study looked at only five research questions, but the growing database might allow
for research into more nuanced relationships within the SRS (such as relationship, goals and
topics, approach or method, and overall). For example, might there be observable differences
between how clients within certain diagnostic criteria rate these specific variables within the
SRS? The larger the database grows the more opportunities there will be for finding statistical
differences between individual variables.
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Growing this type of research database can happen in at least two ways. First, the
application itself must be beneficial enough for clinicians to purchase and use regularly to
continue growing the data. Second, the app could be adopted by mental health or primary care
organizations that have psychotherapy treatment. Both of these routes pose some interesting
ethical considerations.
Security and de-identification of client information is a crucial practice of mental health
clinicians that must be extended when using technology such as the TOMS. The TOMS app deidentifies information through security algorithms and the data is uploaded for analysis.
However, if and when using technology such as the TOMS app becomes more prevalent
throughout private practice and medical organizations, extensive efforts will need to be taken to
ensure the de-identification and security of the data, especially if the data will be used for
research analysis. Access to this data is another thing that should be considered. Nunan and
Domenico (2013) point out how currently in our society big data is gathered through a number of
high-technological firms such Facebook, Google, and other companies that obtain a vast amount
of market research. The collection of big data raises the question of data ownership and how this
data is potentially used. It is important that respondents, both the clinician and client understand
how this data will be used. Some organizations might use outcome data to demonstrate whether
a certain clinician is effective as therapist, which could have implications for compensation and
employability. Another ethical concern is misinterpreting statistical significance from big data.
As noticed in the results, although there were statistical significance found in the data, the effect
sizes were quite small. Competent and careful interpretation of this data is very important, and
similarly the limitations of this research technique must be understood.
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Limitations
Many of the limitations of using an app such as the TOMS for data gathering are identical
to the traditional limitations of effectiveness studies. There are no stringent controls like in
traditional efficacy studies. This leads to a high likelihood of confounding variables. Although
it might be interesting to study differences between geographic differences and ratings scores,
the researcher cannot assess for cultural, social, economic, and clinical factors that are present in
each therapy room where the app is being used. Lack of stringent controls and framework of the
app allows for certain data not to be entered. This makes it difficult to obtain complete results in
each therapy session input. For example, most patients did not have an entered ethnic group
which makes it difficult to observe cultural and ethnic sensitivities.
Another limitation is the need for large sample sizes. Depending on the research question
in mind, certain observations and comparisons might not have enough sample to make the
appropriate analysis. One challenge in the current study was the vast discrepancy in sample sizes
of different groups when trying to compare country of origin or diagnostic criteria differences.
There were certain countries and diagnostic criteria that were more prevalent and had a
significantly larger sample sizes. This type of data gathering tool is largely dependent on the
sample size and more importantly on the diversity of data that is obtained. In efficacy studies,
the researcher has the privilege to find the population or sample they want to study. In
effectiveness studies, particularly Seligman’s (1995) Consumer Reports study, the data gathering
was open ended and voluntary. This is similar in the case of the TOMS app, in which the
researcher is extremely dependent the app is utilized in its entirety by mental health clinicians.
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Another limiting factor of this type of psychotherapy research gathering method is that
the mobile application in question must provide strong benefits and incentives to the user.
Clinicians must benefit from the purchase and use of this technology. This technology must be
easy to use, regularly maintained, updated for new devices and software, and stay relevant to
clinician’s needs. If independent clinicians find little incentives to use this app, or encounter
issues with the software, the sample sizes and data gathering will slow. If organizations decide
to adopt this type of outcome and therapeutic alliance measurement tool, there might be
challenges around security and successful integration of the app into the electronic
health/medical record. Smaller samples sizes will significantly hinder the potential study of this
data set. Regularly updating this type of software also becomes paramount as clinical
psychology research is developing. For example, this application was developed using DSM-IVTR diagnostic criteria domains and currently the profession of clinical psychology has adopted
the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5, 2013).
Future Directions
As technology has developed, so have the implications for researcher and clinicians in the
field of clinical psychology. The TOMS has obvious implications for research and clinical use.
This technology has much potential, which can be explored by continuous developments and
data gathering by the TOMS and similar applications. Larger samples and diverse distribution of
the app will offer more usable data and will allow better analysis.
New developments including mobile applications that utilize other screeners or
measurement tools for clinical use could serve a similar purpose as the TOMS. Currently, many
clinicians and organizations benefit from using the Patient Health Questionnaire (PHQ-9),
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Patient Activation Measure (PAM), SBIRT, and other measures that health track patient data.
Mobile applications, especially if adopted for use by large medical organizations, will provide a
way to gather research data easier and effectively.
The TOMS app itself has strong potential and offers many other paths for data analysis
that were not observed in this study. One specific study that would help evaluate the
effectiveness of using the TOMS for research data gathering is to observe how much of the data
collected is complete and “usable” for research. Consistency of clinician use of the TOMS app
after purchase is another question that might warrant research. This will also provide important
feedback to the developer of the app regarding how regularly and consistently clinicians use their
application. Further in-depth research can also be conducted into looking at the whether there
are observed differences between the four individual variables in each of the SRS and ORS
measures. This particular study looked primarily at overall SRS and ORS scores. However, if
the database grows to a substantial size, individual differences and correlations might be
observed between the various variables of the SRS and ORS.
Conclusion
The future of technology advancement is unforeseen, but likely monumental. The
application of apps such as the TOMS provides a new method of gathering psychotherapy
research that was previously unobtainable on such a large scale.
In 2005, the American Psychological Association Presidential Task Force on EvidenceBased Practice wrote a report discussing the rationale and importance of Evidence-Based
Practice in Psychology (EBPP). The APA defined EBPP as “the integration of the best available
research with clinical expertise in the context of patient characteristics, culture, and preferences”
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(APA, 2006, p. 273). At first, clinical research primarily focused on efficacy studies with
stringent controls to demonstrate strong relationships between treatment and outcomes. With the
Consumer Reports study, Seligman (1995) was able to demonstrate how effectiveness studies
provide an important role in the clinical research field. Effectiveness studies provide research
with potential for diverse sampling, non-manualized treatment, and high external validity. With
developments in mobile technology, using apps such as the TOMS provide a new opportunity
and larger expansion to the original format of effectiveness research. Mobile technology
promotes even larger sample sizes on a global level, data gathering directly in clinical settings,
and active participation from clinicians within private practice or larger organizations. There are
still much to learn and discuss regarding the use of mobile applications for gathering of
psychotherapy research data. There are many important benefits and limitations for both the
clinician and researcher using these types of apps. However, with developments in technology
and shifts towards big data gathering, the TOMS app demonstrates how mobile applications can
be used to gather this type of psychotherapy data. More importantly, this new method of
gathering data provides more research that promotes psychologists’ efforts to integrate research
with clinical expertise in the field of clinical psychology.
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Appendix A
Session Rating Scale (SRS V.3.0)

Name ________________________Age (Yrs):____
ID# _________________________ Gender:_______
Session # ____ Date: ________________________
Please rate today’s session by placing a mark on the line nearest to the description that best
fits your experience.

Relationship
I did not feel heard,
understood, and
respected.

I-------------------------------------------------------------------------I

I felt heard,
understood, and
respected.

Goals and Topics
We did not work on or
talk about what I
wanted to work on and
talk about.

I------------------------------------------------------------------------I

We worked on and
talked about what I
wanted to work on and
talk about.

Approach or Method
The therapist’s
approach is not a
good fit for me.

I-------------------------------------------------------------------------I

The therapist’s
approach is a good fit
for me.

Overall
There was something
missing in the session
today.

I------------------------------------------------------------------------I

International Center for Clinical Excellence
_______________________________________
www.scottdmiller.com

© 2002, Scott D. Miller, Barry L. Duncan, & Lynn Johnson

Overall, today’s
session was right for
me.
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Appendix B
Outcome Rating Scale (ORS)

Name ________________________Age (Yrs):____ Gender_____________
Session # ____ Date: ________________________
Who is filling out this form? Please check one:
Self_______ Other_______
If other, what is your relationship to this person? ____________________________
Looking back over the last week, including today, help us understand how you have been
feeling by rating how well you have been doing in the following areas of your life, where
marks to the left represent low levels and marks to the right indicate high levels. If you are
filling out this form for another person, please fill out according to how you think he or she
is doing.

Individually
(Personal well-being)
I----------------------------------------------------------------------I

Interpersonally
(Family, close relationships)
I----------------------------------------------------------------------I

Socially
(Work, school, friendships)
I----------------------------------------------------------------------I

Overall
(General sense of well-being)
I----------------------------------------------------------------------I
International Center for Clinical Excellence
_______________________________________
www.scottdmiller.com
© 2000, Scott D. Miller and Barry L. Duncan
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Appendix C
Curriculum Vitae

Timofey S. Galuza
8240 SE Buford Ln.
Portland, OR 97236
503-841-8959
tgaluza11@georgefox.edu

EDUCATION

Doctor of Psychology, Clinical Psychology
George Fox University, Newberg, OR
Doctoral Dissertation: Prelim completed Sept. 2014
Graduate Department of Psychology: APA Accredited

Expected May 2016

Pre-doctoral Internship
George Fox Integrated Care Internship
Newberg, OR
APA Accredited Internship

Aug. 2015-Aug. 2016

Master of Arts, Clinical Psychology
George Fox University, Newberg, OR
Graduate Department of Psychology: APA Accredited

Dec. 2013

Bachelor of Arts, Psychology
University of Portland, Portland, OR

May 2011

DOCTORAL INTERNSHIP

Aug. 2015 – Present
George Fox Integrated Care Internship Newberg, OR
Behavioral Health Intern – PMG Happy Valley
 Provide short-term, solution focused behavioral health services within an
integrated primary care and behavioral health model for patients of varying age,
gender, sexual orientation, ethnicity, and socioeconomic status, including
underserved populations.
 Services provided include brief solution focused psychotherapy, behavioral health
consultations, treatment planning, crisis management, participation in warm
handoffs,
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Engaged in coordination of care as part of multidisciplinary team of physicians,
nurses, physician assistants, licensed clinical social workers, and pharmacists.
Other responsibilities include medical chart notes, chart review, consultation with
supervisors, participation in interdisciplinary meetings, and participation in
weekly supervision and didactic meetings.
Provide weekly supervision for clinical psychology doctoral candidates in
community mental health clinic practicum site which includes face to face
supervision, therapy video review, clinical notes review, and clinical training
support.
Conducting an evaluation on patient satisfaction and staff ability in regards to
behavioral health integration across Providence Medical Group clinics with a
behavioral health provider.
Supervisors: Dr. Vanessa Casillas, Psy.D and Dr. Joel Gregor, Psy.D.

SUPERVISED CLINICAL EXPERIENCE

Aug. 2014 – July 2015
Willamette Family Medical Center
Salem, OR
Behavioral Health Intern
 Provide short-term behavioral health services within a co-located primary care
and mental health model for patients for predominately underserved populations.
 Services provided include psychotherapy, psychodiagnostic assessment, treatment
planning, crisis management, behavioral consultations, and participation in warm
handoffs.
 Engaged in coordination of care as part of multidisciplinary team of physicians,
nurse practitioners, physician assistants, and licensed clinical social workers.
 Other responsibilities include medical chart notes, chart review, consultation with
supervisors, assessment report writing, and participation in weekly supervision
and didactic meetings.
 Supervisors: Joel Gregor, Psy.D. and Joshua English, LCSW
Aug. 2013 – Aug. 2014
GFU Behavioral Health Clinic
Newberg, OR
Assessment Coordinator and psychotherapist
 Provided comprehensive assessments for clients seeking psychological testing for
learning disabilities, Attention Deficit/Hyperactivity Disorder, Autism,
personality/behavior assessments, neurocognitive disorders, conduct disorders,
and other reasons for assessment. This includes conducting client interviews, test
administration, scoring, report writing, diagnosis, and making post-assessment
feedback and recommendations.
 Conducted intake interviews, treatment planning, and administrative duties.
 Provided psychotherapy to individuals in the community.
 Provided group therapy for clients managing chronic pain.
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Engaged in weekly didactic training that focused on assessment training, case
conceptualization, group therapy skills, teaching parenting skills, and diagnosisspecific treatment.
Assessment scoring, interpretation, reports, therapy sessions, and therapy
documents were reviewed during individual supervision.
Supervisor: Dr. Joel Gregor, Psy.D.

Sept. 2012 – June 2013
Milwaukie High School
Milwaukie, OR
School Counselor/Psychotherapist
 Provided weekly individual therapy for high school students struggling with
academic, emotional, or social issues.
 Provided intake interviews, observations, consultation, treatment planning, and
report writing.
 Participated in multidisciplinary meetings to design Individualized Education
Plans, Functional Behavioral Assessments, and Behavioral Support Plans.
 Provide psychological assessments to determine students’ levels of functioning
and their eligibility for special education services.
 Therapy interventions, documents, and assessment reports were reviewed in
individual and group supervision.
 Supervisors: Dr. Leslie Franklin, Psy.D. and Dr. Fiorella Kassab, Ph.D.
Jan. 2012 – May 2012
George Fox University
Newberg, OR
Pre-Practicum II
 Provided individual psychotherapy services for volunteer undergraduate students.
 Services included intake interviews, treatment planning, progress notes, and
diagnosis.
 Tasks included report writing, case presentations, consultation with supervisor
and clinical team members.
 Conducted personality assessments and wrote evaluations.
 Supervisor: Mary Peterson, Ph.D., and Laura Heyne, M.A.
Aug. 2011 – Dec. 2011
George Fox University
Newberg, OR
Pre-Practicum I
 Learned basic person-centered therapy skills with group members.
 Tasks included: intake interviews and treatment planning.
 All sessions were taped and reviewed during supervision.
 Supervisors: Mary Peterson, Ph.D., and Laura Heyne, M.A.
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RELEVENT EXPERIENCE & UNIVERSITY INVOLVEMENT

Oct. 2013 – May 2015
Reflex Clinic
Consultant
Tigard, OR
 Provided industrial and organizational psychology consultation services to
evaluate the workplace system and recommend changes to improve employee
review and hiring processes.
 Conducted research-based diagnostics of workplace and performance issues.
 Continued monitoring of system improvements and processes.
 Mapping workplace system, culture, and processes for future replication and
business expansion.
April – Aug. 2014
George Fox Graduate Department of Clinical Psychology
Graduate Teacher Assistant for Social Psychology
Newberg, OR
 Optimized visual presentation through review and modification of PowerPoint
slides, inclusion of relevant videos, and other methods to improve visual
presentations.
 Graded writing assignments and input grades.
 Provided assistance and guidance to students.
 Supervisor: Joel Gregor, Psy.D.
April 4-6, 2013
Christian Association for Psychological Studies International Conference
Presenter, Volunteer, and CE Monitor
Portland, OR
 Conducted research presentation
 Monitored attendance and CE sign in/sign out.
 Helped set up the seating and introduced presenters.
 Provide assistance and information to presenters and attendees.
May 2010 – June 2010
Autism Intervention Internship
Portland, OR
Intern
 Partook in a play-based treatment program with an autistic boy, followed specific
guidelines and goals set by the Son-Rise program to help him develop language
and social skills in a positive and supportive environment.
 Built a genuine and fun relationship with the child, while striving to increase
communication, interactive attention span, flexibility, and eye contact.
 Focused on using the child’s motivations and interests, and building upon them to
improve social skills and communication.
PROFESSIONAL AFFILIATIONS

2012 – Present
2011 – Present
2010 – Present

Oregon Psychological Association (Student Affiliate)
American Psychological Association (Student Affiliate)
Psi Chi National Honor Society
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RESEARCH EXPERIENCE & PRESENTATIONS

Feb. 2011 – May 2015
Graduate Department of Clinical Psychology
Research Vertical Team Member
Newberg, OR
 Participate in bi-weekly meetings to discuss research projects, including
dissertations, supplemental research, research conferences, and other topics
relating to research.
 Presented personal dissertation research and progress. Collaborated on group
research projects, and discussed research ideas for future projects
 Faculty Advisor: Mark McMinn, Ph.D.
Doctoral Dissertation: Using Big Data in Psychotherapy Research: Possibilities and Perils
 Dissertation Chair: Mark McMinn, Ph.D., ABPP/CL
 Committee Members: Mary Peterson, PhD, ABPP; Joel Gregor, Psy.D.
 Preliminary defense completed: Sept. 24, 2014
Presentations:
Engle, N. W., Barr, B., Galuza, T. (2014, May). Organizational psychology for medical
clinic culture. Poster presented at annual meeting of the Oregon Psychological
Association, Portland, OR
McMinn, M. R., Birch, R., Galuza, T., & Rodriguez, J. M., (2013, April). A Comparison
of Religious and Spiritual Diversity Training at Religious and other
Institutions. Presentation at the annual meeting of the Christian Association of
Psychological Studies, Portland, OR.
Rodriguez, J. R., Birch, R., Galuza, T., & McMinn, M. R. (2013, August). Religious and
Spiritual Diversity Training at Explicitly Religious Doctoral Programs. Poster
was presented at the annual meeting of the American Psychological Association,
Honolulu, HI

PROFESSIONAL TRAINING AND WORKSHOPS

Nov. 7-8, 2015

Acceptance & Commitment Therapy - An Experiential and Practical
Introduction
Dr. Jason Luoma, Ph.D. and Dr. Jenna LeJeune, Ph.D.
Site: LifeQual Center

Oct. 21, 2015

Let’s talk about Sex: Managing Emerging Sexuality in Therapy
Dr. Joy Mauldin, Psy.D.
Site: George Fox University
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Aug. 10-14, 2015

Integrated Care Bootcamp
Dr. Joel Gregor, Psy.D., Dr. Mary Peterson, Ph.D., Jeri Turgesen, Psy.D.,
Vanessa Casillas, Psy.D., Juliette Cutts, Psy.D., Kristin Garcia, Psy.D.,
Julie Oyemaja, Psy.D., and Joy Mauldin, Psy.D.
Site: George Fox University

March 18, 2015

Spiritual Formation & Psychology
Dr. Barrett McRay, Psy.D.
Site: George Fox University

Feb. 26, 2015

Workshop on Criminal Justice-Behavioral Health Issues
Dr. Annette Matthews, MD, Dr. Jonathan Barker, MD, Jason Myers, Dr.
Stephanie Maya Lopez, MD, and Dr. Karl Mobbs, MD.
Oregon Psychiatric Physician’s Association in partnership with the
American Psychiatric Association
Site: DoubleTree by Hilton Portland

Nov. 19, 2014

Face Time in an Age of Technological Attachment
Dr. Doreen Dodgen-Magee, Psy.D.
Site: George Fox University

Oct. 15, 2014

Understanding and Treating ADHD in Children
Dr. Erika Doty, Psy.D.
Learning Disabilities: A Neuropsychological Perspective
Dr. Tabitha Becker, Psy.D
Site: George Fox University

Aug. 18-22, 2014

Workplace Development for Integrated Behavioral Healthcare
Dr. Joel Gregor, Psy.D., Dr. Julie Oyemaja, Psy.D., Dr. Mary Peterson,
Ph.D., Dr. Jeri Turgesen, Psy.D.
Site: George Fox University

March 12, 2014

Evidenced Based Treatment for PTSD in Veteran Populations:
Clinical and Integrative Perspectives
Dr. David Beil-Adaskin, Psy.D.
Site: George Fox University

Jan. 15, 2014

DSM V, Essential Changes in Form and Function
Dr. Jeri Turgesen, Psy.D. and Dr. Mary Peterson, Ph.D., ABPP
Site: George Fox University

Sept. 25, 2013

Integrated Primary Care
Dr. Brian Sandoval, Psy.D. and Dr. Juliette Cutts, Psy.D.
Site: George Fox University
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May 31, 2013

Psychological Assessment Conference: Using Tests of Effort in
Psychological Assessment
Dr. Paul Green, Ph.D.
Site: George Fox University

May 31, 2013

Assessing Mild Cognitive Impairment and Dementia
Dr. Mark Bondi, Ph.D., ABPP
Site: George Fox University

March 6, 2013

The Person of the Therapist
Dr. Brooke Kuhnhausen, Ph.D.
Site: George Fox University

Jan. 30, 2013

African American History, Culture and Addictions and Mental
Health Treatment
Danette C. Haynes, LCSW, and Dr. Marcus Sharpe, Psy.D.
Site: George Fox University

Nov. 14, 2012

Sexual Identity
Dr. Erica Tan, Psy.D.
Site: George Fox University

Oct. 10, 2012

Treating Gender Variant Clients: Christian Integration
Dr. Erica Tan, Psy.D.
Site: George Fox University

June 8, 2012

Psychological Assessment Conference: Assessment and Treatment of
Anger, Aggression, & Bullying in Children and Adults; and The MiniMental State Examination – 2nd Edition
Dr. Ray DiGiuseppe, Ph.D., and Dr. Joel Gregor, Psy.D.
Site: George Fox University

March 7, 2012

Mindfulness and Christian Integration
Dr. Erica Tan, Psy.D
Site: George Fox University

LANGUAGES SPOKEN

English, Russian
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TEST ADMINISTRATION, SCORING, AND REPORT WRITING EXPERIENCE

Adult Measures (and wide age-range measures)
 16PF – Fifth Edition
 Adaptive Behavior Assessment System – Second Edition (ABAS-II)
 Adult Asperger Assessment (AAA)
 Becks Depression Inventory-II (BDI-II)
 Behavior Rating Inventory of Executive Function – Adult Version (BRIEF-A)
 California Verbal Learning Test – 2nd Edition (CVLT-II)
 Conners’ Adult ADHD Rating Scales (CAARS)
 Conners’ Continuous Performance Test II (CPT II V.5)
 Controlled Oral Word Association (COWA)
 Delis-Kaplan Executive Function System (D-KEFS)
 Halstead-Reitan Neuropsychological Battery
 Millon Clinical Multiaxial Inventory – III (MCMI-III)
 Minnesota Multiphasic Personality Inventory – II (MMPI-II)
 Minnesota Multiphasic Personality Inventory – II – RF (MMPI-II-RF)
 Minnesota Multiphasic Personality Inventory – Adolescent (MMPI-A)
 Peabody Picture Vocabulary Test - Fourth Edition (PPVT-4)
 Personality Assessment Inventory (PAI)
 Rey Complex Figure Test and Recognition Trial (RCFT)
 Ritvo Autism-Asperger’s Diagnostic Scale – Revised (RAADS-R)
 Test of Memory Malingering (TOMM)
 Vineland Adaptive Behavior Scales, 2nd Edition
 Wechsler’s Adult Intelligence Scale – Fourth Edition (WAIS-IV)
 Wechsler’s Individual Achievement Test- Third Edition (WIAT-III)
 Wide Range Intelligence Test (WRIT)
 Wide Range Achievement Test – Fourth Edition (WRAT4)
 Wide Range Assessment of Memory and Learning – Second Edition (WRAML-2)
 Wisconsin Card Sorting Test (WCST)
 Woodcock-Johnson Tests of Achievement – Third Edition (WJ-III)
Child and Adolescent Measures
 Achenbach Child Behavior Checklist (CBCL)
 Behavioral Assessment System for Children, Second Edition (BASC-II)
 Behavior Rating Inventory of Executive Function (BRIEF)
 Child Bipolar Questionnaire (CBQ) – Version 2.0
 Childhood Autism Rating Scale, 2nd Ed. (CARS2)
 Conners 3rd Edition (Conners 3)
 Gilliam Asperger’s Disorder Scale (GADS)
 Millon Pre-Adolescent Clinical Inventory (M-PACI)
 Personality Assessment Inventory – Adolescent (PAI-A)
 Personality Inventory for Youth (PIY)
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Roberts Apperception Test for Children 2 (Roberts-2)
Wechsler’s Intelligence Scale for Children – Fourth Edition (WISC-IV)
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